CME Group Inc. (CME)

CME Group Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	3,186	2,657	2,617	2,105	2,117
Depreciation & Amortization	352.6	362.6	385.4	464.4	473.3
Share-Based Compensation	82.9	84.3	75.2	96	73.1
Other Operating Activities	-207.9	-81.9	-694.6	50	9.9
Operating Cash Flow	3,454	3,056	2,402	2,716	2,673
Operating Cash Flow Growth	13.02%	27.21%	-11.53%	1.60%	9.51%
Capital Expenditures	-76.4	-89.7	-87.9	-197.5	-245.6
Acquisitions	95.5	-402	144.7	20.8	89.6
Change in Investments	1.8	1.9	1.6	1.2	3.4
Investing Cash Flow	20.9	-489.8	58.4	-175.5	-152.6
Dividends Paid	-3,235.5	-2,633.5	-2,189.3	-2,110	-1,695.9
Debt Issued / Paid	-16.4	-15.2	0	-304.6	-661.7
Other Financing Activities	-45,087.4	-22,733	72,098	49,661	-2,361.7
Financing Cash Flow	-48,339.3	-25,381.7	69,909	47,247	-4,719.3
Net Cash Flow	-44,864.6	-22,815.5	72,370	49,787	-2,199.1
Free Cash Flow	3,377	2,966	2,315	2,518	2,427
Free Cash Flow Growth	13.86%	28.16%	-8.09%	3.75%	4.44%
Free Cash Flow Margin	60.54%	59.10%	49.35%	51.56%	49.86%
Free Cash Flow Per Share	9.41	8.27	6.46	7.04	6.80

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).